Related Experiment Videos
Re: Response of aleukemic granulocytic sarcoma to all-trans-retinoic acid plus interferon alfa-2a
Journal of the National Cancer Institute
|January 15, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Lasofoxifene versus fulvestrant for ER+/HER2- metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.
NPJ precision oncology·2022
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Early palliative care for African American and rural-dwelling advanced cancer family caregivers: long-term outcomes.
Journal of the National Cancer Institute·2026
Critical appraisal of combination therapies: the impact of trial design on Benefit-Risk outcomes.
Journal of the National Cancer Institute·2026
Alcohol consumption and colorectal cancer risk in prediabetes and diabetes: a nationwide cohort study.
Journal of the National Cancer Institute·2026
Physical activity and molecular residual disease in stage III colon cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80702.
Journal of the National Cancer Institute·2026
Temporal trends in relative survival and excess mortality among US adults with lymphoid malignancies.
Journal of the National Cancer Institute·2026
Temporal treatment trends for ductal carcinoma In situ by race and ethnicity in the United States.
Journal of the National Cancer Institute·2026